Clinical Trials - Pregnancy
Short Study Name |
Protocol Title |
Principal Investigator |
Site(s) |
| PreTerm Birth - Mom | A Phase 3B, multi-center, randomized, double-blind study of Hydroxyprogesterone caproate injection, 250 mg/ml, versus vehicle for the prevention of preterm birth in women with a pervious singleton spontaneous preterm delivery | Dennis Worthington, MD |
Wheaton Franciscan - St. Joseph Campus |
For information on enrolling in clinical trials, please call or email:
Kelli Holton, Regulatory Affairs Assistant
(414) 874-4541